ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Hot Features

Registration Strip Icon for alerts Cadastre-se para alertas em tempo real, use o simulador personalizado e observe os movimentos do mercado.

ASND Ascendis Pharma AS

144,83
2,73 (1,92%)
23 Abr 2024 - Fechado
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
Ascendis Pharma AS ASND NASDAQ Recibo de Depósito
  Variação do Dia (p) Variação do Dia % Último Preço Hora
2,73 1,92% 144,83 19:14:27
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
143,30 143,30 147,45 144,83 142,10
mais cotações »

Notícias Recentes

Data Hora Fonte Título
04/03/202410:30GLOBEAscendis Pharma to Participate in the Leerink Partners..
07/02/202418:01GLOBEAscendis Pharma Reports Fourth Quarter and Full Year 2023..
07/02/202410:30GLOBEAscendis Pharma to Participate in the Oppenheimer 34th..
31/01/202418:15GLOBEAscendis Pharma to Report Full Year 2023 Financial Results..
31/01/202418:01GLOBEAscendis Pharma Launches 2nd TransCon™ Product: YORVIPATH®..
29/01/202410:30GLOBENew Company Eyconis Formed to Develop Ascendis Pharma..
08/01/202410:20GLOBEVector Pharma FZCO Announce Exclusive Distribution Agreement..
07/01/202419:45GLOBEAscendis Pharma Introduces Vision 2030
07/01/202416:00PRNUSSpecialised Therapeutics signs exclusive agreement with..
28/12/202318:15GLOBEAscendis Pharma to Participate in the 42nd Annual J.P...
20/12/202310:30GLOBESignificant Health and Quality of Life Improvements Achieved..
19/12/202310:30GLOBETransCon™ hGH (lonapegsomatropin) Achieved Statistically..
11/12/202310:30GLOBEFDA Accepts for Review Resubmitted NDA for TransCon PTH..
29/11/202306:30GLOBEAscendis Pharma Announces Strategic Partnership with Teijin..
20/11/202310:00GLOBEAscendis Pharma Announces European Commission Approval of..
15/11/202310:00GLOBEAscendis Pharma Resubmits NDA for TransCon™ PTH to the U.S...
07/11/202318:01GLOBEAscendis Pharma Reports Third Quarter 2023 Financial Results
31/10/202309:30GLOBEAscendis Pharma Announces Timing of Third Quarter 2023..
26/10/202309:30GLOBEAscendis Presents Updated and New TransCon™ IL-2..
16/10/202317:01GLOBEAscendis Pharma Presents TransCon™ PTH (palopegteriparatide)..
02/10/202309:00GLOBEAscendis Presents TransCon™ PTH Data at the American Thyroid..
23/09/202308:00GLOBEAscendis Pharma Presents Results from Long-Term enliGHten..
15/09/202309:00GLOBEAscendis Pharma Launches SKYTROFA® (lonapegsomatropin) in..
14/09/202313:22GLOBEAscendis Pharma Receives Positive CHMP Opinion for TransCon™..
05/09/202317:15GLOBERoyalty Pharma and Ascendis Pharma Enter Into $150 Million..
05/09/202317:03GLOBEAscendis Pharma Reports Second Quarter 2023 Financial..
05/09/202317:01GLOBEAscendis Pharma and Royalty Pharma Enter into $150 Million..
24/08/202309:30GLOBEAscendis Pharma A/S Announces Three Upcoming Investor..
15/08/202309:30GLOBEAscendis Pharma to Report Second Quarter 2023 Financial..
17/06/202318:30GLOBEOne-Year Data from Phase 3 Trial of TransCon™ PTH in Adults..
13/06/202308:00GLOBEAscendis Pharma Showcases Its Latest Endocrinology Programs,..
07/06/202309:30GLOBEAscendis Pharma to Participate in the Goldman Sachs 44th..
05/06/202318:30GLOBEAscendis Pharma Opens Compassionate Use Program for..
31/05/202309:30GLOBEAscendis Pharma Oncology Program Update Highlights Latest..
25/05/202309:30GLOBEAscendis Pharma to Host Oncology Program Update on May 31
13/05/202320:00GLOBEAscendis Pharma Showcases Commitment to Rare Endocrine..
03/05/202317:15GLOBEAscendis Pharma to Participate in the BofA Securities 2023..
01/05/202319:50DJNADRs End Lower; Avadel Pharmaceuticals Gets Boost From FDA
01/05/202309:16DJNAscendis Shares Rally Premarket as FDA Doesn't Seek New..
01/05/202308:00GLOBEU.S. Food & Drug Administration Issues Complete Response..
27/04/202317:01GLOBEAscendis Pharma Reports First Quarter 2023 Financial Results

Seu Histórico Recente

Delayed Upgrade Clock